TrialBlood2009

Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996).

Peter L Greenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.